In June, the international journal *Innovations in Clinical Neuroscience* reported that a 54-year-old female patient's depression symptoms worsened after four weeks of semaglutide treatment
[PubMed: 14739123] 872
Taking up an integrated care model may facilitate communications and support provision of care, and ultimately improve patient-reported outcomes, anxiety symptoms, and well-being for people receiving dialysis
Laparoscopic sleeve gastrectomy is recommended for patients with MASH and type 2 diabetes or obesity
Side effects and how to minimize them DSIP appears to be well-tolerated in research settings, with no major toxicity identified even at high doses
Now, it's time for policymakers, employers and insurers to work with pharmaceutical companies to ensure no one is left behind in receiving the care they deserve and need." A four-week supply of the 2.5 mg Zepbound single-dose vial is $399 ($99.75 per vial), and a four-week supply of the 5 mg dose is $549 ($137.25 per vial) less than half the list price of other incretin medicines for obesity and in line with the Zepbound savings program for non-covered individuals